Editor’s Choice: A New CRISPR Trial, Revelations About Zika-Related GBS, and Parents Taking Action

Happy Thursday!

This week, we have details on the beginnings of a new trial testing CRISPR gene editing for Duchenne muscular dystrophy, how parents can play a critical role in developing treatments for rare diseases, and new findings about Zika virus-associated Guillain-Barre syndrome.

source: pixabay.com

The FDA Grants Approval to Begin Dosing First-in-Human CRISPR Technology to Treat Duchenne Muscular Dystrophy

Could CRISPR gene-editing help achieve a breakthrough for Duchenne muscular dystrophy? A new trial is about to begin.




source: shutterstock.com

Study of the Week: Zika Virus-Related Guillain-Barre Syndrome Linked to Worsened Olfactory Function

Recent research has revealed the Guillain-Barre syndrome caused by infection with the Zika virus appears to result in reduced sense of smell.

source: shutterstock

Parents Develop Drugs to Help Their Children with Rare Diseases

Parents of patients with rare diseases play a central role in spearheading rare disease research and drug development.




Do you have a rare disease experience of your own? Share with us here.

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email